Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 65.00%
Date: 21-04-2026
Price: $0.175
Last Price: $0.130
Post-Signal Low Price: $0.130
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail
The last three months have been tough on Rhythm Biosciences Limited (ASX:RHY) shareholders, who have seen the share price decline a rather worrying 54%. But over three years the performance has been really wonderful. The longer term view reveals that the share price is up 785% in that period. As lon
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality
It might be of some concern to shareholders to see the Rhythm Biosciences Limited (ASX:RHY) share price down 18% in the last month. But that doesn't displace its brilliant performance over three years. Over that time, we've been excited to watch the share price climb an impressive 585%. As long term
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history laud
AI Confidence - 65.00 % model confidence
Rhythm Biosciences Limited is a molecular diagnostics company specializing in developing and commercializing proprietary biomarker tests for early detection of colorectal cancer. The company operates primarily in the healthcare diagnostics market, targeting a growing demand for non-invasive cancer screening solutions, but remains a small player with limited market penetration and commercial scale to date.
| Cash Flow | Weak |
| Debt | Moderate |
| Profitability | Weak |
| Revenue Trend | Downtrend |
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Oversold |
| Support Level | $ 0.15 |
| Resistance Level | $ 0.22 |